Short-Term Effects of Valsartan on Congestive Heart Failure
PU Dong-y
Abstract
PU Dong-y
Abstract
Objective To observe the short-term efficacy of Valsartan on patients with congestive heart failure(CHF).Methods Sixty-five patients with CHF were randomly divided into two groups.The control group(n=33) was given routine therapy,and the treatment group(n=32) was given Valsartan(80 mg,once a day) in addition to routine therapy.Echocardiography was performed before the treatment and 6 months later.Results Twenty cases were with apparent effective and 8 cases responded slightly in the treatment group,and the total effective rate was 87.5%.In control group,there were 14 cases with apparent effective and 8 cases responded slightly,the total effective rate was 66.7%.The difference was obviously (P0.05).LVEF,LVEDV,LVESV,SV and CO were all improved at various degrees in the treatment group compared with the control group (P0.05~0.01).Conclusions Valsartan can effectively control heart failure.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the short-term efficacy of Valsartan on patients with congestive heart failure(CHF).Methods Sixty-five patients with CHF were randomly divided into two groups.The control group(n=33) was given routine therapy,and the treatment group(n=32) was given Valsartan(80 mg,once a day) in addition to routine therapy.Echocardiography was performed before the treatment and 6 months later.Results Twenty cases were with apparent effective and 8 cases responded slightly in the treatment group,and the total effective rate was 87.5%.In control group,there were 14 cases with apparent effective and 8 cases responded slightly,the total effective rate was 66.7%.The difference was obviously (P0.05).LVEF,LVEDV,LVESV,SV and CO were all improved at various degrees in the treatment group compared with the control group (P0.05~0.01).Conclusions Valsartan can effectively control heart failure.
Key concepts: Medicine, Valsartan, Heart failure, Ejection fraction, Cardiology, Internal medicine, Blood pressure